Elevating future therapies to a new level: Greenovation transformed into Eleva. Join us at www.elevabiologics.com

We develop highly efficient biopharmaceuticals in plants

We at Greenovation develop next generation therapeutics using our proprietary BryoTechnology platform.

Our core competency is optimization and effective production of highly-efficient glycoproteins for the treatment of orphan diseases.

GMP compliant manufacturing of our products is performed in Greenovation’s state-of-the-art wave-bag bioreactor system.

Greenovation is a privately owned biopharmaceutical company based in Heilbronn, Germany, that was founded in 1999 by Prof. Dr. Ralf Reski and Prof. Dr. Gunther Neuhaus. Today, Zukunftsfonds Heilbronn and
L-Bank (Karlsruhe) are main owners of the Greenovation Biotech GmbH.